The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice

The prevalence of immune-mediated liver diseases such as autoimmune liver disease or viral hepatitis has increased in recent years, and the side effects of pre-existing treatments are a worldwide problem. Regulatory T cells (Tregs) and T helper 17 (Th17) cells play important roles in the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Han, Feng, Xinxia, Han, Ping, Lei, Yu, Xia, Yujia, Tian, Dean, Yan, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854585/
https://www.ncbi.nlm.nih.gov/pubmed/31638166
http://dx.doi.org/10.3892/mmr.2019.10750

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854585/
https://www.ncbi.nlm.nih.gov/pubmed/31638166
http://dx.doi.org/10.3892/mmr.2019.10750

Ejemplares similares